FDA priority review

3 new FDA drug approvalsFDA recently approved 3 major drugs to treat lung cancer, prostate cancer, and cystic fibrosis. Here are the top 3 new drug approvals.
AbbVie hopes to advance HCV treatment for genotype 4AbbVie’s investigational hepatitis C virus (HCV) cocktail has been granted FDA priority review April 23 for the treatment of adult patients with chronic genotype 4 (GT4) HCV infection—the first investigational drug combination for GT4 infection, which accounts for about 6% of HCV cases in the United States.